A hydrogel-based implantable multidrug antitubercular formulation outperforms oral delivery.
Nanoscale. 2021 Aug 21;13(31):13225-13230. doi: 10.1039/d0nr08806d. Epub 2021 Jul 30.
Nanoscale. 2021.
PMID: 34477730